What is Colonic Stents Market?
Colorectal cancer is one of the commonly encountered cancers across the Western World and constitutes the third most common ranked cancer and the second most common ranked cause of cancer-related deaths in the United Kingdom. A colonic stent is a hollow cylindrical tube, generally made of metal or an alloy which helps to keep the lumen of the large bowel open and used to relieve complete or partial large bowel blockage. Colonic stent placement is the most effective technique used for patients with colon cancer or other forms of bowel blockage.
The market study is being classified by Type (Self-Expandable Metal Stents, Nitinol Stent and Elgiloy), by Application (Colorectal Cancer/Bridge to Surgery, Benign Colonic Strictures and Other Indications) and major geographies with country level break-up.
Boston Scientific Corporation (United States), Cook Medical Incorporated (United States), ELLA-CS, Ltd. (Czechia), Taewoong Medical Co. Ltd. (South Korea), Prion Medical (Belgium), Becton, Dickinson and Company (United States), Synergie Médicale (Canada), Olympus America Inc. (United States) and BVM Medical Ltd. (United Kingdom) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Colonic Stents market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Colonic Stents market by Type, Application and Region.
On the basis of geography, the market of Colonic Stents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Colorectal cancer among People
- Rise in the Number of Diagnostic Centres and Hospitals in Developing Countries
- Increasing Preference for Minimally Invasive Procedures
- Increasing Awareness about Cancer Treatment
- Complications Associated with Colonic Stents Placement
- Growth in the Healthcare Sector
- Technological Advancements in The Medical Science
- Stringent Government Rules and Regulations
Recently, Boston Scientific Corporation has announced it has signed an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement (TAVR).
Key Target AudienceColonic Stents Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase